Ann: Pfizer raises scheme consideration to A$0.208 per share, page-81

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 81 Last

Share
Profile

Follow
blakesley

329 Posts.

78

09/08/22

17:35

Post #: 63016251
Share

Originally posted by bigblackbear: ↑

Quote EL "Thanks for sharing. With respect, taking into account the size of your holding, I’m assuming the Board / Pfizer must be trying to improve the headcount vote component, or otherwise wouldn’t really make sense - very interesting. I hope they call me again. I’ll be telling them I honestly think 27.9 cents will get this over the line, however that my NO vote remains unchanged at this price. I’ve got friends, family and associates with significant holdings as well that are taking the same approach."

Agree 100%, such that as a SIGNIFICANT HOLDER (600K+ shares), I have changed my vote to NO. I have also gone one step further and bought $500 parcels for relatives, and convinced them all to vote NO.
My proviso to this, I will change my vote to YES if Pfizer at least up their bid to the top end of the IEReport of 27.9c.
Pfizer/BOD RAP the clock is ticking on this one, I would expect a revised/upped bid to hit by Friday am.
I too hope they call me again, however the calling is being outsourced and some of these telemarketers have NO IDEA how to handle/classify the information they're being given by the NO shareholders. IMHO. DYOR.
In my personal opinion, Pfizer have no issue in getting the 75% YES votes (shares voted) but are finding they DO HAVE AN ISSUE with getting the 50% YES of ALL SHAREHOLDERS who vote on the scheme resolution (ie alot of retail/small holders are voting NO).

If any of you holders have a large social media following I would press you to use that reach to get the word out further that a NO vote will work in upping the bid to a price that at least rewards the longer term shareholder (and takes future risk away from them for a more reasonable price)
In my research the technology is not a done deal, there are still risks, and I have spoken to users of the technology and not all are 100% happy with it, but they expect it to improve over time (with $$$$ injected)

Expand

The IER fair value estimate is so conservative it isn't funny.

I think shareholders are being conditioned so we will think we are getting the upper end of the IER range so we should be happy.

Nope, the IER needs further justification as to why it has adopted the assumptions it has and how multi years worth of revenue have been accounted for. Which from my looking at it doesn't. I don't think the IER is clear on that point at all.

Just my opinion.

RAP Price at posting: 19.0¢ Sentiment: Hold Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

EXR

Essential Energy conference: Elixir talks up unlocking QLD's Taroom Trough

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Essential Energy conference: Streamlining approvals key to the green energy transition

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

There are more pages in this discussion • 21 more messages in this thread...

First 81 Last

Add RAP (ASX) to my watchlist

Ann: Pfizer raises scheme consideration to A$0.208 per share, page-81

Top Stories

Essential Energy conference: Elixir talks up unlocking QLD's Taroom Trough

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Essential Energy conference: Streamlining approvals key to the green energy transition

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Featured News